Estimates 2- and 5-year treated kidney failure risk in CKD stages G3–G5.
Overview
Estimates 2- and 5-year treated kidney failure risk in CKD stages G3–G5.
Clinical Significance
Estimates treated kidney failure risk; calibration differs by region and population.
When to Use
- Use as decision support when all required inputs are reliable.
How It Is Calculated
- North American 4-variable KFRE equation using age, sex, eGFR and urine ACR.
Interpretation
- Estimates treated kidney failure risk; calibration differs by region and population.
Worked Example
Enter verified values in the displayed units; MedicalC applies the published equation or point system.
Limitations
- Prediction models may be miscalibrated outside their derivation population.
- Measurement and classification error can materially change the result.
Clinical Pearls
- Document source values and units with the result.
- Use trends and the full clinical picture.
Common Mistakes
- Wrong units.
- Using non-contemporaneous inputs.
- Treating the output as a diagnosis or mandatory treatment decision.
Frequently Asked Questions
What does this tool calculate?
Estimates 2- and 5-year treated kidney failure risk in CKD stages G3–G5.
Can the result be used alone?
No. Interpret it with the complete clinical assessment and current guidance.
References
- Tangri N et al. JAMA. 2011;305:1553-1559. — Primary or supporting reference for the implemented model.
Reviewed by: MedicalC Clinical Editorial Team
Last reviewed: July 2026
